Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord-derived stem cells and platelet-rich plasma for resistant lateral epicondylitis
IRCT20231206060276N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 3 trial of platelet-rich plasma in Lateral Epicondylitis (LET) and medial epicondylitis, sponsored by Mazandaran University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
Lateral Epicondylitis (LET)medial epicondylitis
Beyond the preview
Go deeper on IRCT20231206060276N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231206060276N1.